Jian-yu Weng - Publications

Establishment and Mechanistic Study of Venetoclax-Resistant Cell Lines in Acute Myeloid Leukemia

Journal: Zhongguo shi yan xue ye xue za zhi

Published: September 11, 2025

Identification of a Novel MAPK1::BCR Fusion Gene/t(9;22) (q34;q11) in a Case of Acute Promyelocytic Leukemia

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: July 09, 2024

Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase.

Journal: American journal of hematology

Published: March 13, 2023

Targeting Bcl-6 prevents sclerodermatous chronic graft-versus-host disease by abrogating T follicular helper differentiation in mice.

Journal: International immunopharmacology

Published: December 04, 2022

Mesenchymal stem cells reversibly de-differentiate myofibroblasts to fibroblast-like cells by inhibiting the TGF-β-SMAD2/3 pathway.

Journal: Molecular medicine (Cambridge, Mass.)

Published: November 21, 2022

Disruption of mitochondrial oxidative phosphorylation by chidamide eradicates leukemic cells in AML.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: November 16, 2022

Mutant C/EBPα p30 alleviates immunosuppression of CD8+ T cells by inhibiting autophagy-associated secretion of IL-1β in AML.

Journal: Cell proliferation

Published: December 20, 2021

Clinical Effect of Tyrosine Kinase Inhibitors in the Treatment of P230 Chronic Myeloid Leukemia

Journal: Zhongguo shi yan xue ye xue za zhi

Published: December 11, 2021

The Establishment and Identification of Acute Myeloid Leukemia NOD-SCID-IL2rg-/-Mice Model by Using Luciferase-Expressing KG1a Cells

Journal: Zhongguo shi yan xue ye xue za zhi

Published: October 10, 2021

Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome.

Journal: Biomarker research

Published: March 03, 2021

The efficacy and safety of CAR-T cell therapy in patients with refractory ALL and concomitant HBV infection.

Journal: Leukemia

Published: May 10, 2020

Expression and Significance of BTLA and Its Ligand HVEM in Patients with Chronic Myelomonocytic Leukemia

Journal: Zhongguo shi yan xue ye xue za zhi

Published: February 07, 2020